サマリー

ヘッジホッグ経路阻害剤の世界市場 2022-2026 年
Technavioはヘッジホッグ経路阻害剤市場を監視しており、2022-2026年の間に3855万ドルの成長が見込まれ、予測期間中にCAGR13%で加速しています。当レポートでは、ヘッジホッグ経路阻害剤市場の全体分析、市場規模・予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、BCCおよびAMLの高リスク要因、老年人口の増加、BCCおよびAMLに関する認知度の上昇によって牽引されています。
ヘッジホッグ経路阻害剤市場の分析には、適応症セグメントと地理的展望が含まれます。
Technavioのヘッジホッグ経路阻害剤市場は、以下のようにセグメント化されています。
適応症別
- BCC
- AML
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間のヘッジホッグ経路阻害剤市場の成長を促進する主な理由の1つとして、再利用型製剤の開発が挙げられています。また、戦略的提携や癌関連研究への資金提供は、市場の大きな需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。ヘッジホッグ経路阻害剤市場に関する当レポートは、以下の分野を対象としています。
- ヘッジホッグ経路阻害剤の市場サイジング
- ヘッジホッグ経路阻害剤の市場予測
- ヘッジホッグ経路阻害剤市場の産業分析
Technavioの強固なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Bristol Myers Squibb Co., Infinity Pharmaceuticals Inc., F. Hoffmann La Roche Ltd., Inhibitor Therapeutics Inc, MAX BioPharma Inc, Mayne Pharma Group Ltd, Novartis AG, Pfizer Inc, Sanofi, Sun Pharmaceutical Industries Ltd. および BridgeBio Pharma Inc. など複数の主要ハリネズミ経路阻害剤市場ベンダーに関する詳細分析を提供している。また、ヘッジホッグ経路阻害剤の市場分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/hedgehog-pathway-inhibitors-market-size-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Indication
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Indication
o 5.1 Market segments
o Exhibit 24: Chart on Indication - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Indication - Market share 2021-2026 (%)
o 5.2 Comparison by Indication
o Exhibit 26: Chart on Comparison by Indication
o Exhibit 27: Data Table on Comparison by Indication
o 5.3 BCC - Market size and forecast 2021-2026
o Exhibit 28: Chart on BCC - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on BCC - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on BCC - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on BCC - Year-over-year growth 2021-2026 (%)
o 5.4 AML - Market size and forecast 2021-2026
o Exhibit 32: Chart on AML - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on AML - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on AML - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on AML - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Indication
o Exhibit 36: Market opportunity by Indication ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Canada - Market size and forecast 2021-2026
o Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.9 Germany - Market size and forecast 2021-2026
o Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.10 UK - Market size and forecast 2021-2026
o Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.11 China - Market size and forecast 2021-2026
o Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 BridgeBio Pharma Inc.
o Exhibit 85: BridgeBio Pharma Inc. - Overview
o Exhibit 86: BridgeBio Pharma Inc. - Product / Service
o Exhibit 87: BridgeBio Pharma Inc. - Key news
o Exhibit 88: BridgeBio Pharma Inc. - Key offerings
o 10.4 Bristol Myers Squibb Co.
o Exhibit 89: Bristol Myers Squibb Co. - Overview
o Exhibit 90: Bristol Myers Squibb Co. - Product / Service
o Exhibit 91: Bristol Myers Squibb Co. - Key offerings
o 10.5 F. Hoffmann La Roche Ltd.
o Exhibit 92: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 93: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 94: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 95: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 96: F. Hoffmann La Roche Ltd. - Segment focus
o 10.6 Inhibitor Therapeutics Inc
o Exhibit 97: Inhibitor Therapeutics Inc - Overview
o Exhibit 98: Inhibitor Therapeutics Inc - Product / Service
o Exhibit 99: Inhibitor Therapeutics Inc - Key offerings
o 10.7 MAX BioPharma Inc.
o Exhibit 100: MAX BioPharma Inc. - Overview
o Exhibit 101: MAX BioPharma Inc. - Product / Service
o Exhibit 102: MAX BioPharma Inc. - Key offerings
o 10.8 Mayne Pharma Group Ltd.
o Exhibit 103: Mayne Pharma Group Ltd. - Overview
o Exhibit 104: Mayne Pharma Group Ltd. - Business segments
o Exhibit 105: Mayne Pharma Group Ltd. - Key news
o Exhibit 106: Mayne Pharma Group Ltd. - Key offerings
o Exhibit 107: Mayne Pharma Group Ltd. - Segment focus
o 10.9 Novartis AG
o Exhibit 108: Novartis AG - Overview
o Exhibit 109: Novartis AG - Business segments
o Exhibit 110: Novartis AG - Key offerings
o Exhibit 111: Novartis AG - Segment focus
o 10.10 Pfizer Inc.
o Exhibit 112: Pfizer Inc. - Overview
o Exhibit 113: Pfizer Inc. - Product / Service
o Exhibit 114: Pfizer Inc. - Key news
o Exhibit 115: Pfizer Inc. - Key offerings
o 10.11 Sanofi
o Exhibit 116: Sanofi - Overview
o Exhibit 117: Sanofi - Business segments
o Exhibit 118: Sanofi - Key news
o Exhibit 119: Sanofi - Key offerings
o Exhibit 120: Sanofi - Segment focus
o 10.12 Sun Pharmaceutical Industries Ltd.
o Exhibit 121: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 122: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 123: Sun Pharmaceutical Industries Ltd. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 124: Inclusions checklist
o Exhibit 125: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 126: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 127: Research methodology
o Exhibit 128: Validation techniques employed for market sizing
o Exhibit 129: Information sources
o 11.5 List of abbreviations
o Exhibit 130: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Indication - Market share 2021-2026 (%)
Exhibits25: Data Table on Indication - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Indication
Exhibits27: Data Table on Comparison by Indication
Exhibits28: Chart on BCC - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on BCC - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on BCC - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on BCC - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on AML - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on AML - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on AML - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on AML - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Indication ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: BridgeBio Pharma Inc. - Overview
Exhibits86: BridgeBio Pharma Inc. - Product / Service
Exhibits87: BridgeBio Pharma Inc. - Key news
Exhibits88: BridgeBio Pharma Inc. - Key offerings
Exhibits89: Bristol Myers Squibb Co. - Overview
Exhibits90: Bristol Myers Squibb Co. - Product / Service
Exhibits91: Bristol Myers Squibb Co. - Key offerings
Exhibits92: F. Hoffmann La Roche Ltd. - Overview
Exhibits93: F. Hoffmann La Roche Ltd. - Business segments
Exhibits94: F. Hoffmann La Roche Ltd. - Key news
Exhibits95: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits96: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits97: Inhibitor Therapeutics Inc - Overview
Exhibits98: Inhibitor Therapeutics Inc - Product / Service
Exhibits99: Inhibitor Therapeutics Inc - Key offerings
Exhibits100: MAX BioPharma Inc. - Overview
Exhibits101: MAX BioPharma Inc. - Product / Service
Exhibits102: MAX BioPharma Inc. - Key offerings
Exhibits103: Mayne Pharma Group Ltd. - Overview
Exhibits104: Mayne Pharma Group Ltd. - Business segments
Exhibits105: Mayne Pharma Group Ltd. - Key news
Exhibits106: Mayne Pharma Group Ltd. - Key offerings
Exhibits107: Mayne Pharma Group Ltd. - Segment focus
Exhibits108: Novartis AG - Overview
Exhibits109: Novartis AG - Business segments
Exhibits110: Novartis AG - Key offerings
Exhibits111: Novartis AG - Segment focus
Exhibits112: Pfizer Inc. - Overview
Exhibits113: Pfizer Inc. - Product / Service
Exhibits114: Pfizer Inc. - Key news
Exhibits115: Pfizer Inc. - Key offerings
Exhibits116: Sanofi - Overview
Exhibits117: Sanofi - Business segments
Exhibits118: Sanofi - Key news
Exhibits119: Sanofi - Key offerings
Exhibits120: Sanofi - Segment focus
Exhibits121: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits122: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits123: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits124: Inclusions checklist
Exhibits125: Exclusions checklist
Exhibits126: Currency conversion rates for US$
Exhibits127: Research methodology
Exhibits128: Validation techniques employed for market sizing
Exhibits129: Information sources
Exhibits130: List of abbreviations